Skip to main content
Clinical Trials/NCT03781388
NCT03781388
Completed
Phase 4

ED90 for Hyperbaric Bupivacaine in Spinal Anesthesia for Cesarean Delivery in Super Obese Parturients

Duke University1 site in 1 country45 target enrollmentMay 1, 2019

Overview

Phase
Phase 4
Intervention
Bupivacaine
Conditions
Obesity, Morbid
Sponsor
Duke University
Enrollment
45
Locations
1
Primary Endpoint
Percent of successful blocks for operation (success operation)
Status
Completed
Last Updated
15 days ago

Overview

Brief Summary

The aim of this study is to determine the ED90 of hyperbaric intrathecal bupivacaine for the super obese population undergoing cesarean section under a combined spinal epidural technique.

Registry
clinicaltrials.gov
Start Date
May 1, 2019
End Date
December 6, 2022
Last Updated
15 days ago
Study Type
Interventional
Study Design
Sequential
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiology (ASA) class 2 and 3
  • English speaking
  • Gestational age \> 36 weeks
  • Scheduled for cesarean delivery under combined spinal epidural anesthesia
  • 18 years or older
  • BMI \> 50 kg/m2

Exclusion Criteria

  • History of past or current intravenous drug or chronic opioid abuse
  • Allergy or contraindication to any study medications
  • Intrapartum cesarean delivery under epidural anesthesia
  • Cesarean delivery under general anesthesia

Arms & Interventions

Starting dose of Bupivacaine (9.75 mg)

The starting dose of hyperbaric bupivacaine for the first patient in this study will be 9.75mg; the dose for the subsequent subject will be based on the response of the preceding subject as per the Narayana Rule, a modification of the biased-coin design (BCD) up-down sequential method (UDM).

Intervention: Bupivacaine

Subsequent dose

Intervention: Bupivacaine

Outcomes

Primary Outcomes

Percent of successful blocks for operation (success operation)

Time Frame: during surgery up to 90 minutes after intrathecal injection

successful initial sensory level without requiring additional epidural anesthetic

Percent of successful blocks for induction (success induction)

Time Frame: 10 minutes after intrathecal drug administration

bilateral T6 sensory level to pinprick by

Number of Participants With Successful Blocks for Induction (Success Induction)

Time Frame: 10 minutes after intrathecal drug administration

Bilateral T6 sensory level to pinprick

Number of Participants With Successful Blocks for Operation (Success Operation)

Time Frame: during surgery up to 90 minutes after intrathecal injection

Successful initial sensory level without requiring additional epidural anesthetic

ED90 (90% Effective Dose) of Intrathecal Bupivacaine for Cesarean Delivery

Time Frame: 90 minutes

Study Sites (1)

Loading locations...

Similar Trials